Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for OLANZAPINE
- Psychopharmacological Treatment of Emotional Distress
- A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Co-Administration of Roluperidone and Olanzapine in Adult Subjects With Moderate to Severe Negative Symptoms of Schizophrenia
- Prevention of Breakthrough CINV in Patients Receiving Moderately or Highly Emetogenic Chemotherapy
- The Danish Out-of-Hospital Cardiac Arrest Study
- Effect of RDX-002 on Postprandial Triglycerides in Subjects Treated With Olanzapine
- A Study of the Efficacy of Fecal Microbiota Transplantation(FMT) in the Treatment of Schizophrenia
- Sequenced Treatment in Adolescents With Major Depression (STAMD): a Multicenter Open-label Randomized Controlled Trial
- Olanzapine and 5-HT3 With or Without Dexamethasone to Prevent CINV
- A Study of Olanzapine in Patients With Acute Agitation
- Add-on Aripiprazole on Cardiometabolic Profile in Treatment Resistant Schizophrenia: RCT
- Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced and Incurable Solid Tumors
- A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label, Long-Term Safety Phase to Evaluate the Efficacy and Safety of TV-44749 in Adults With Schizophrenia
- The Impact of Preoperative Olanzapine on Quality of Recovery After Discharge From Ambulatory Surgery
- Empagliflozin Addition in Modulating Metabolic Disturbances Associated With Olanzapine in Schizophrenia Patients
- A Study on the Efficacy of Agomelatine Combined With Antipsychotics to Treat Negative Symptoms in Schizophrenia
- Tocilizumab, Dexamethasone, Olanzapine, Hemodynamics, and Ventilation in Cardiac Surgery
- Steroid-sparing Therapy (Olanzapine) Versus Dexamethasone-based Therapy for Chemotherapy-induced Nausea and Vomiting
- Study of the Breast Milk Pharmacokinetics of Olanzapine and Samidorphan
- Vortioxetine Adjunctive Treatment in Bipolar Depression
- Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Patients With Advanced Cancer
- Low Dose Olanzapine to the Prophylaxis of Nausea and Vomiting Induced by Chemotherapy in Children and Adolescents
- Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
- Olanzapine Combined With Fosaprepitant, Ondansetron, and Dexamethasone for Preventing Nausea and Vomiting in Patients With Testicular Cancer
- Olanzapine in Anorexia Cachexia Syndrome Among Advanced Cancer Patients
- Fosaprepitant , Tropisetron and Olanzapine for the Prevention of Nausea and Vomiting in Patients With Breast Cancer Receiving Anthracycline/Cyclophosphamide-containing Chemotherapy
- The Safety and Efficacy of Lurasidone In Subjects With Schizophrenia Switched From Olanzapine
- The Optimization of Antiemetic Regimen for C-RINV in LA-HNSCCs
- Olanzapine in OUD Patients
- Comparing Olanzapine and Mirtazapine in the Improvement of Unintentional Weight Loss for Patients With Advanced Stage Cancer
- Fasted Bioequivalence Study of 2 Olanzapine Film-coated Tablets, 5 mg, in Healthy, Adult Male and Female Subjects.
- Phase 1 Study of OLZ/SAM in Pediatric Subjects With Bipolar I Disorder
- Modified Tian Wang Bu Xin Dan Hydrogel Patch in Preventing Postoperative Delirium in Elderly Patients
- Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients
- Capsaicin to Prevent Delayed Chemotherapy Induced Nausea and Vomiting (CapCIN)
- Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication?
- Low Dose Amisulpride Vs Olanzapine-Fluoxetine Combination in Post-Schizophrenic Depression
- HALO Trial: Haloperidol vs Olanzapine in Hyperactive Delirium in Advanced Cancer Patients; A Multi-Centre, Randomised-Controlled Trial
- A Study of Different Dosing Schedules of Selinexor in Sarcoma Patients
- Comparing Haloperidol and Olanzapine in Treating Terminal Delirium
- Olanzapine for the Prevention of Postoperative Nausea and Vomiting
- Efficacy of Olanzapine, Netupitant and Palonosetron in Controlling Nausea and Vomiting Associated With Highly Emetogenic Chemotherapy in Patients With Breast Cancer
- Olanzapine Plus Fosaprepitant Standard Antiemetic Therapy in the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients Receiving High Emetic Risk Multi-day Chemotherapy: a Multicenter, Randomized, Double-blind, Placebo-controlled, Phase
- Olanzapine for Nausea/Vomiting Prophylaxis in Recipients of Hematopoietic Stem Cell Transplants
- Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Obese Adult Patients With Schizophrenia While Taking Antipsychotic Medications (GRATITUDE II)
- Clinical Intervention on Cognitive Impairment of Schizophrenia With Metabolic Syndrome
- Olanzapine for the Prevention of Chemotherapy Induced Nausea and Vomiting in Gynecologic Oncology Patients
- "Extended" (Alternate Day) Antipsychotic Dosing
- Efficacy of Online CBT for GAD Compared to Pharmaceutical Interventions
- Study to Determine the Safety, Tolerability, and Efficacy of Evenamide in Patients With Chronic Schizophrenia
- Effect of Vortioxetine on Cognitive Symptoms in Patients With Schizophrenia
- Olanzapine or Dexamethasone, With 5-HT3 RA and NK-1 RA, to Prevent CINV
- Amisulpride Treatment for BPSD in AD Patients
- Olanzapine for Chemotherapy-induced Nausea and Vomiting Prophylaxis
- Definitive Selection of Neuroimaging Biomarkers for the Diagnosis and Treatment to Common Mental Disorders
- Acute Olanzapine and Lipid Response
- The Treatment Efficacy of Combination Atypical Antipsychotics With Sertraline in Patients With Schizophrenia
- Feasibility of Olanzapine at REduced doSe in hIGHly Emetogenic chemoTherapy
- Rolapitant Plus Olanzapine in Multiday Cisplatin Chemotherapy
- The Effect of CORT118335 on Olanzapine-Induced Weight Gain
- Olanzapine Versus Aprepitant Based Antiemetic Regimen for High Emetic Chemotherapy
- Clozapine Versus Olanzapine as Treatment for Comorbid Psychotic Disorder and Substance Use Disorder
- Identification of Multi-modal Bio-markers for Early Diagnosis and Treatment Prediction in Schizophrenia Individuals
- Proposal To Develop A Rapid And Cost-Effective Diagnostic Test For Schizophrenia
- Xenon Inhalation Therapy for Major Depressive Disorder and Bipolar Disorder
- Intranasal Insulin and Olanzapine Study in Healthy Volunteers
- Early Predictors of Poor Treatment Response in Patients With Schizophrenia Treated With Atypical Antipsychotics
- Pre-operative Olanzapine as Prophylactic Antiemetic in Oncologic Patients
- Safety and Tolerability of INP105 (Olanzapine by I231 POD® Device) Nasal Spray in Healthy Volunteers - SNAP 101
- Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
- Olanzapine Improves the Chemotherapy Tolerance of Advanced Gastric Cancer
- Bromocriptine for Patients With Schizophrenia and Impaired Glucose Tolerance
- Olanzapine for the Prevention and Treatment of Nausea and Vomiting Induced by Chemotherapy of Lung Cancer
- A Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adults With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical Antipsychotic
- A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication
- Chinese First Episode Schizophrenia's Optimal Dynamic Antipsychotic Treatment Regime
- Trial to Evaluate Efficacy of Olanzapine With Short-acting 5HT3 Inhibitors in Chemotherapy-induced Nausea & Vomiting (CINV) Prophylaxis
- Netupitant/Palonosetron Hydrochloride and Dexamethasone With or Without Prochlorperazine or Olanzapine in Improving Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer
- Lurasidone Vs Olanzapine on Neurotrophic Biomarkers and Cardiometabolic Parameters in Unmedicated Schizophrenia
- Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor
- Oral Olanzapine Versus Haloperidol or Diazepam
- Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
- "Olanzapine for Prevention of Chemotherapy Induced Nausea and Vomiting in Children and Adolescents Receiving Highly Emetogenic Chemotherapy (HEC)"
- Randomised Trial Ketiapine Olanzapine Fast Sedation Agitated Patients Emergency Ward
- Study to Evaluate the Efficacy of ALKS 3831 on Body Weight in Young Adults Who Have Been Recently Diagnosed With Schizophrenia, Schizophreniform, or Bipolar I Disorder
- Saxenda® in Obese or Overweight Patients With Stable Bipolar Disorder (Investigator Initiated)
- Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Advanced Cancer Patients
- RCT of Olanzapine for Control of CIV in Children Receiving HSCT Conditioning
- Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Chinese Breast Cancer Patients
- Olanzapine for Acute Headaches
- Melatonin Use in the Intensive Care Elderly Population
- Berberine as Adjuvant Treatment for Schizophrenia Patients
- Olanzapine for the Treatment of Refractory Chronic Nausea and Vomiting
- Sequential Therapy for the Treatment of Severe Bipolar Depression.
- Proof-of-Concept Trial of Palonosetron and Olanzapine Without Dexamethasone for the Prevention of CIN
- Aripiprazole as an Adjunct to Atypical Antipsychotics for Weight Reduction and Improvement in Metabolic Profile
- Aprepitant- and Olanzapine- Containing Anti-emetic Regimens With High Dose Melphalan
- Enhancing Recovery in Early Schizophrenia
- An Insulin Sensitivity Study in Healthy Subjects
- Long-acting Paliperidone Palmitate Injection and Olanzapine for Schizophrenia
- Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
- Individualised Versus Standard Care for Breast Cancer Patients at High-risk for Chemotherapy-induced Nausea and Vomiting The ILIAD Study
- Trial and Follow-up of the Efficacy of Two-stage Integrated Treatment for Chinese Schizophrenia Inpatients
- A Phase 1 Safety Study in Adults With Schizophrenia
- MEtformin and Lorcaserin for WeighT Loss in Schizophrenia
- Olanzapine for Nausea After Surgery
- Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
- Aripiprazole, Abilify Maintena Collaborative Clinical Protocol
- Molecular Mechanisms of Antipsychotic-induced Insulin Resistance
- Olanzapine vs. Low-dose Olanzapine Plus Trifluoperazine
- A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
- The Role of miR-30 Family Dysregulation in Response to Antipsychotic Treatment
- Metformin for Treatment Antipsychotic-induced Metabolic Syndrome in Bipolar Disorder Patients
- Utility of Olanzapine in the Treatment of Opioid Withdrawal in the ED
- Switching From Twice-Daily to Once-Daily Clozapine Dosing in Schizophrenia
- Study of FOND Versus FOND+O for the Prevention of CINV in Hematology Patients Receiving Highly Emetogenic Chemotherapy Regimens
- Whole Blood and Plasma Sample Collection for the Development of Antipsychotic Immunoassays From Participants Taking Aripiprazole, Olanzapine, Paliperidone, or Risperidone
- A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
- Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)
- Integrating Psychotropic Medication Into the Care of People With Mental Disorders in a Prayer Camp in Ghana
- Antipsychotics and Risk of Hyperglycemic Emergencies
- Clozapine Versus Other Atypical Antipsychotics for Bipolar Disorder
- Nicotinic Receptors and Schizophrenia
- The Effects of Antipsychotic Drugs on Brain Metabolism in Healthy Individuals
- Metformin for Overweight & OBese ChILdren and Adolescents With BDS Treated With SGAs
- Aprepitant ,Olanzapine,Palonosetron and Dexamethasone for the Prevention of Chemotherapy-induced Nausea and Vomiting
- A Study to Assess the Clinical Utility of Antipsychotic Medication Levels in Plasma as Determined by Liquid Chromatography-Tandem Mass Spectrometry
- Effect of Short Term Atypical Antipsychotic Administration Compared to Placebo on Hepatic Insulin Extraction
- 5-HTR2A, DRD2,and COMT Genes Polymorphisms and Olanzapine Plasma Concentration in Treatment of Early-onset Schizophrenia
- A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or Schizophreniform
- Neuroendocrine and Metabolite Substrates in Schizophrenia
- Selinexor With Multiple Standard Chemotherapy or Immunotherapy Regimens in Treating Patients With Advanced Malignancies
- A Randomized Study of Olanzapine for the Prevention of CINV in Patients Receiving Moderately Emetogenic Chemotherapy
- IM Olanzapine Versus Haloperidol or Midazolam
- Pharmacovigilance in Gerontopsychiatric Patients
- Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients
- Olanzapine Against Delayed Nausea and Vomiting in Women Receiving Carboplatin Plus Paclitaxel
- Olanzapine Versus Lithium in the Treatment of Acute Depression in Patients With Bipolar II or Bipolar Not Otherwise Specified(OL Study)
- Study of the Effects of Pantoprazole on Levels of Prescribed Psychiatric Medications
- A Randomized Double-blind Trial With 6 Antipsychotic Drugs for Schizophrenia
- Antipsychotic to Treat Psychosis Syndrome
- Olanzapine for Prevention of Chemotherapy-induced Nausea and Vomiting in Children: A Multi-Centre Feasibility Study
- Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic Chemotherapy
- Pilot Study of Olanzapine and Aprepitant to Prevent Nausea and Vomiting in Children Receiving Chemotherapy
- Association of Amisulpride Response in Schizophrenia With Brain Image
- A Four-week Clinical Trial Investigating Efficacy and Safety of Cannabidiol as a Treatment for Acutely Ill Schizophrenic Patients
- Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants
- Cannabidiol as a Different Type of an Antipsychotic: Drug Delivery and Interaction Study
- Intuniv vs Placebo in the Treatment of Childhood Intermittent Explosive Disorder
- Sodium Benzoate for Treatment of Attenuated/Transient Psychosis. A Randomized Placebo-controlled Trial.
- Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Olanzapine Orally Disintegrating 5mg Tablets Under Fed Condition
- Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Olanzapine Orally Disintegrating 5mg Tablets Under Fasting Condition
- Neurobiology of Eating Disorders Treatments
- Atypical Antipsychotics for Continuation and Maintenance Treatment After an Acute Manic Episode
- Assessment and Comparison of Metabolic Changes in Non-psychotic Adults Taking Iloperidone or Olanzapine or Placebo
- A Study of ALKS 3831 in Adults With Schizophrenia
- Comparative Efficacy and Acceptability of Antimanic Drugs in Acute Mania
- Olanzapine Compared to Lamotrigine in the Prevention of Depressive Episode in the Patients With Bipolar Disorder
- Does a GLP-1 Receptor Agonist Change Glucose Tolerance in Antipsychotic-treated Patients?
- NMDA Antagonists in Bipolar Depression
- Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective Psychosis
- Pioglitazone for the Treatment of Bipolar Depression
- Safety and Efficacy of Aripiprazole and Ziprasidone Among Schizophrenic Patients With Metabolic Syndrome
- A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression
- A Pilot Study on the Efficacy and Safety of Olanzapine in Gastroparesis
- Long-Term Safety Extension Trial of Asenapine in Schizophrenia Participants Who Completed Protocol P05688 (P05689)
- A Study of the Efficacy and Safety of Asenapine in Participants With an Acute Exacerbation of Schizophrenia (P05688)
- Comparison of Antipsychotic Combination Treatment of Olanzapine and Amisulpride to Monotherapy
- A Study to Compare Capillary and Venous Whole Blood and Plasma Concentrations of Five Antipsychotics
- Melatonin for Prevention of Metabolic Side Effects of Olanzapine
- Efficacy and Safety Evaluation of Carbamazepine for Prevention of Chemotherapy-induced Nausea and Vomiting
- Alleviating the Metabolic Side Effects of Antipsychotic Medications
- A Study of Flexibly Dosed Paliperidone Extended Release Tablets in Participants With Schizophrenia
- Early Recognition and Optimal Treatment of Delirium in Patients With Advanced Cancer
- Minocycline for Bipolar Depression
- Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fed Condition
- Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fasting Condition
- Bioequivalence Study of Olanzapine Tablets, 5 mg Under Fed Study
- Bioequivalence Study of Olanzapine Tablets, 5 mg of Dr. Reddy's Under Fasting Conditions
- An Observational Drug Utilization Study of Asenapine in the United Kingdom (P08308)
- Metabolic Effects of Olanzapine in Healthy Males
- Treatment on Iatrogenic Weight Gain and Dyslipidaemia Associated With Olanzapine
- Four Interventions in the Management of Psychomotor Agitation, Safety and Efficacy Evaluation
- Bergen Psychosis Project 2 - The Best Intro Study
- Sustaining Remission of Psychotic Depression
- Acute Impact of Intramuscular (IM) Aripiprazole and Olanzapine on Insulin Resistance in High Risk Prediabetics
- A Follow up Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder
- Prevention of Relapse With Injectable Paliperidone Palmitate Versus Oral Antipsychotics
- Effects of Sulfasalazine on BOLD Response to Alcohol Cues
- Efficacy of Olanzapine Monotherapy for Treatment Bipolar Ⅰ Depression
- Effects of Adjunctive Metformin on Metabolic Profiles in Clozapine-treated Schizophrenic Patients
- Reboxetine and Citalopram as an Adjunct Treatment to Second Generation Antipsychotics in the Treatment of Negative Symptoms of Schizophrenia
- Risperidone vs. Olanzapine as add-on Treatment in Treatment Resistant Depression
- Optimization of Treatment and Management of Schizophrenia in Europe
- A Study of RO4917838 (Bitopertin) in Patients With Acute Exacerbation of Schizophrenia
- Atypical Antipsychotic Treatment Effect On Brain Function In Schizophrenia Measured By FMRI
- Reducing Antipsychotic-Induced Weight Gain in Children With Metformin
- Switching to Iloperidone From Other Antipsychotics in Schizophrenia
- Efficacy of Quetiapine XR Versus Placebo as Concomitant Treatment to Mood Stabilizers in the Control of Subsyndromal Symptoms of Bipolar Disorder
- Twelve Month Study Comparing Paliperidone Palmitate and Select Oral Antipsychotics in Adults With Schizophrenia Who Have Been Recently Discharged From an Inpatient Psychiatric Hospital
- Antipsychotics and Gene Expression in Soft Tissues
- Evaluation of the Efficacy and Safety of Olanzapine for Anorexia Nervosa in Children and Adolescents
- Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
- Olanzapine Versus Placebo for Outpatients With Anorexia Nervosa
- Evaluation of Co-Administration of Betahistine as Adjunctive to Olanzapine in Healthy Subjects
- Clinical Effectiveness of Newer Antipsychotics in Comparison With Conventional Antipsychotics in Schizophrenia
- Effect of Atypical Antipsychotic Drugs Olanzapine and Amisulpride on Glucose Metabolism
- 15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated
- Effect of Olanzapine on Sleep Electroencephalogram (EEG) in Schizophrenia Patients
- Comparison of Olanzapine and Metoclopramide For Treatment Of bReakThrough Emesis
- Study of Blood Lactate Levels in Patients Treated With Antipsychotics
- A Long-Term, Open-Label, Study on Schizophrenia
- Clozapine and Olanzapine Treatment of Aggression
- Prevention of Relapse With Injectable Paliperidone Palmitate Versus Oral Antipsychotics
- Standard Comprehensive Intervention to Treat First-episode Schizophrenia
- Therapeutic Drug Monitoring in Child and Adolescent Psychiatry
- Pragmatic RCT Comparing Aripiprazole, Olanzapine and Haloperidol in the Treatment of Schizophrenia
- Efficacy of an Early Antipsychotic Switch in Case of Poor Initial Response to the Treatment of Schizophrenia
- TC-5619 as Augmentation Therapy to Improve Cognition in Outpatients With Cognitive Dysfunction in Schizophrenia
- Efficacy & Safety of SCH 900435 in Schizophrenia (Study P06079)(WITHDRAWN)
- Study in Adolescents With Schizophrenia or Bipolar Disorder
- Telmisartan as an Adjunctive Treatment for Metabolic Problems in Patients With Schizophrenia
- Interaction Between Fosamprenavir/Ritonavir and a Single-dose Olanzapine (FORZA)
- A Study of Olanzapine in Patients With Schizophrenia
- Mood Stabilizer (MS)+ Antidepressant vs MS + Placebo in Maintenance of Bipolar Disorder.
- A Study in Relapse Prevention of Treatment-Resistant Depression
- Identification and Treatment Response Prediction of Antipsychotic-Related Metabolic Syndrome
- Use, Effects and Side-effects of Second-generation Antipsychotics in a Naturalistic Setting
- Tardive Dyskinesia and Cognitive Function
- Polypharmacy in Clozapine-resistant Schizophrenia
- Healthy Volunteers Study of the Effects of Olanzapine and Ziprasidone
- Metabolic Effects of Antipsychotic Substitution in Children
- Intravenous Palonosetron With Radiotherapy and Concomitant Temozolomide
- Examining the Effects of Antipsychotic Medications on Insulin Sensitivity
- Comparing the Effects of Sertindole and Olanzapine on Cognition (SEROLA)
- Olanzapine for the Treatment of Appetite Loss in Amyotrophic Lateral Sclerosis (ALS)
- Compare the Efficacy and Tolerability of the Combination of Aripiprazole and Selective Serotonin Reuptake Inhibitors (SSRIs) Used in Major Depression
- Sertindole in Asian Patients With Schizophrenia
- Trial Comparing the Effects of Aripiprazole With Those of Standard of Care on Non-HDL Cholesterol in Patients With Schizophrenia or Bipolar I Disorder Who Have Metabolic Syndrome
- Effectiveness and Safety of Atypical Antipsychotic Agents in Augmenting SSRI-Refractory Obsessive-Compulsive Disorder
- Evaluation of Safety, Drug-Drug Interactions and Pharmacokinetic Profiles of Co-Administration of Betahistine With Olanzapine in Healthy Female Subjects
- Exenatide for the Treatment of Weight Gain Associated With Olanzapine in Obese Adults
- A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients
- A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression
- Pilot Study to Evaluate the Efficacy and Safety of Quetiapine Fumarate Instant-Release (Seroquel IR) in Controlling Agitation and Aggressive Symptoms in the Acute Treatment of Patients With Schizophrenia
- Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia
- Haloperidol vs Olanzapine for the Management of ICU Delirium
- A Study to Test the Safety and Efficacy of MK-8998 in Acutely Psychotic Participants With Schizophrenia (MK-8998-004)
- D-serine Monotherapy for Schizophrenia
- Comparison of Optimal Antipsychotic Treatments for Adults With Schizophrenia
- Intramuscular (IM) Olanzapine Versus IM Haloperidol Plus Lorazepam for Acute Agitation in Schizophrenia
- Aggressive Treatment of Metabolic Syndrome in Patients Receiving Clozapine for Schizophrenia
- Study to Evaluate the Efficacy and Safety of Armodafinil as Adjunctive Therapy in Adults With Schizophrenia
- Efficacy of Lu 31-130 in Patients With Schizophrenia
- A Study in the Treatment of Acute Mania
- Chromium Piccolinate in the Prevention of Weight Gain Induced by Serotonergic Medications Initiated on Psychiatric Inpatient Units.
- Study on Metabolic Parameters of Sertindole in Patients With Schizophrenia
- Exploratory Cognition Study of Sertindole in Patients With Schizophrenia
- A New Pharmacotherapy for Alcohol Dependence: Olanzapine
- A Crossover Study of the Acute Effects of Olanzapine in Healthy Volunteers
- Opioids With or Without Olanzapine in Treating Patients With Moderate to Severe Cancer Pain
- Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic Subjects
- An Efficacy and Safety Study of 3 Fixed Doses of JNJ-37822681 in Participants With Schizophrenia
- Minimizing Doses of Antipsychotic Medication in Older Patients With Schizophrenia.
- Comparative Study of Aripiprazole and Olanzapine in the Treatment of Patients With Acute Schizophrenia
- Prophylactic Olanzapine Versus Placebo for Prevention of Postoperative Delirium After Joint Replacement Surgery
- Effectiveness of Olanzapine Versus Placebo in Treating Outpatients With Anorexia Nervosa
- Demonstrate the Effects of Pramlintide on Weight Reduction in Schizophrenia
- Phase IIA Study in Patients With Schizophrenia
- Effectiveness of Atypical Antipsychotic Medication for Outpatients With Anorexia Nervosa
- Metformin for the Prevention of the Metabolic Side-effects of Zyprexa
- Ondansetron With Olanzapine for the Treatment of Alcohol Dependence: A Preliminary Clinical Trial
- Cardio Risk of Acute Schizophrenia Olanzapine Duke
- Effectiveness of Antipsychotic Combination With Psychosocial Intervention on Outcome of Patients With Schizophrenia
- A 52-week, Open-label Extension Study Following a 6-week, Double-blind, Placebo- and Active- Controlled Study (R076477-SCH-303) to Evaluate the Safety and Tolerability of Paliperidone ER in Subjects With Schizophrenia
- Fasting Study of Olanzapine Tablets 5 mg and Zyprexa® Tablets 5 mg
- Fasting Study of Olanzapine Tablets 20 mg and Zyprexa® Tablets 20 mg
- Food Study of Olanzapine Tablets 5 mg and Zyprexa® Tablets 5 mg
- A 6 Month Study to Compare the Metabolic Effects of Paliperidone ER and Olanzapine in Patients With Schizophrenia
- A 4-week, Randomized, Rater-blinded, Parallel Study to Evaluate Quetiapine in Improving Sleep Quality of Schizophrenia
- A Study Comparing Rapid Acting Intramuscular Olanzapine and Placebo in Agitated Patients With Schizophrenia
- Oxcarbazepine as an Adjunct of Antipsychotic Therapy in Acute Schizophrenia
- Effects of Modafinil on Olanzapine Weight Gain
- Ziprasidone in the Treatment of Borderline Personality Disorder
- Neuroleptic and Huntington Disease Comparison of : Olanzapine, la Tetrabenazine and Tiapride
- Metabolic Effects of Subchronic Dopamine D2 Receptor Blockade by Antipsychotic Drugs in Healthy Humans
- Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Tardive Dyskinesia
- Safety and Efficacy of Olanzapine in the Long-term Treatment for Bipolar I Disorder, Depressed
- A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
- Lurasidone HCl A Phase 3 Study of Patients With Acute Schizophrenia
- Paroxetine-CR (Paxil-CR) in the Treatment of Patients With Fibromyalgia Syndrome
- Olanzapine in the Treatment of Anorexia Nervosa
- Optimal Duration of Olanzapine Add-on Therapy in Major Depression
- Effectiveness of Lithium and Valproate in Treating High-Risk Bipolar Disorder
- Quetiapine vs. Placebo in Alcohol Relapse Prevention - a Pilot Study
- Effects of Atypical Antipsychotic and Valproate Combination Therapy on Glucose and Lipid Metabolism in Schizophrenia
- The Effects of Rimonabant, on Weight and Metabolic Risk Factors
- Metabolic Profile and Anthropometric Changes in Schizophrenia
- A Study for Patients With Schizophrenia
- An Investigation of the Sleep Architecture and Consequent Cognitive Changes in Olanzapine-Treated Depressed Patients
- Glucose and Lipid Metabolism on Antipsychotic Medication
- Subcutaneous Olanzapine for Hyperactive or Mixed Delirium
- Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine
- An Observational Study of Olanzapine Coated and Orodispersible Tablets Effectiveness in Schizophrenic and Bipolar Outpatients.
- Olanzapine Treatment of Patients With Bipolar I Disorder
- Use of Galantamine and CDP-choline (Citicoline) to Treat Adults With Schizophrenia
- A Phase 4 Study to Assess the Effects of Aripiprazole Versus Other Atypical Antipsychotics in the Treatment of Schizophrenic Patients With Metabolic Syndrome
- Study of the Effectiveness of Quetiapine for the Treatment of Alcohol Dependency
- Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual
- A Study to Evaluate the Effectiveness and Safety of Extended-Release (ER) Paliperidone Compared With Placebo in Delaying the Recurrence of Symptoms in Bipolar I Disorder
- Olanzapine in Patients With Advanced Cancer and Weight Loss
- The Paliperidone ER Observational Study of Economic, Functional, and Clinical Outcomes in Patients With Schizophrenia
- Pilot Study of Atomoxetine To Enhance COgnition In Patients With Schizophrenia
- Weight Gain Management in Patients With Schizophrenia
- Comparison of Intramuscular Olanzapine and Intramuscular Haloperidol in Patients With Schizophrenia
- Assessment of a Weight Management Program for Weight Gain in Patients With Schizophrenia
- Examining Rapid Acting Intra-Muscular Olanzapine in Japanese Patients With Schizophrenia
- Olanzapine/Fluoxetine Combination Versus Comparator in the Treatment of Bipolar I Depression
- Olanzapine Versus Comparator in the Treatment of Bipolar Disorder
- Managing Acute Schizophrenia, a Comparison Between Two Atypical Antipsychotics
- A Safety and Efficacy Study of Bacopa Monnieri and Nardostachys Jatamansi to Treat Schizophrenia
- Guanfacine Adjunctive Treatment to Atypical Antipsychotics for Cognitive Dysfunction in Schizophrenia
- A Two-Week Study of the Efficacy and Safety of Mifepristone in the Prevention of Olanzapine-Induced Weight Gain
- Diabetes in Neuropsychiatric Disorders
- Zyprexa and Task Engagement in Schizophrenia
- Efficacy and Safety of AVE1625 as a Co-treatment With Antipsychotic Therapy in Schizophrenia
- Safety and Efficacy Trial of Olanzapine in Outpatients With Pathological Gambling
- Discontinuation of Antipsychotics and Antidepressants Among Patients With BPSD
- Study to Examine the Effect of Betahistine on Body Weight Gain Due to Olanzapine Treatment
- Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
- Modulation of Regional Brain Activation in Schizophrenic Patients by Pharmacological Therapy
- Large Simple Trial (LST) Of Cardiovascular Safety Of Ziprasidone And Olanzapine- (Zodiac)
- A Comparison of Olanzapine in Combination With a Mood Stabilizer vs Mood Stabilizer Alone, in Mixed Bipolar Patients
- Assessment of Safety and Efficacy of Therapy for the Prevention of Weight Gain Associated With Olanzapine
- A Study to Evaluate Effectiveness and Safety of ER OROS Paliperidone in Patients With Schizophrenia
- Topiramate vs. Placebo in Preventing Weight Gain in Bipolar Disorder Treated With Olanzapine
- An Open-label Trial of Metformin for Weight Control of Pediatric Patients on Antipsychotic Medications.
- A Study to Evaluate the Efficacy and Safety of Risperidone for the Prevention of Mood Episodes in the Treatment of Patients With Bipolar I Disorder
- Medication, Weight Gain and GI Hormones
- Study Comparing the Affect of Bifeprunox Vs Olanzapine on Weight During the Treatment of Outpatients With Schizophrenia.
- A Study Comparing Three Strategies to Switch Patients With Schizophrenia or Schizoaffective Disorder to Risperidone After Unsuccessful Treatment With Olanzapine.
- Aripiprazole in the Treatment of Patients With Schizophrenia and Symptoms of Obsessive Compulsive Disorder (OCD)
- A Study of Zonisamide to Prevent Olanzapine-Associated Weight Gain
- A Placebo-Controlled, Cross-Over Trial of Aripiprazole
- Ziprasidone for Clozapine- or Olanzapine-Associated Diabetes Mellitus
- A Randomized, Active-controlled, Double-blind, Parallel-Goup Study of the Efficacy and Safety of Extended Release(ER) Paliperidone in the Treatment of Schizophrenia
- Clinical Trial of Dipyridamole in Schizophrenia
- Switch Study of Existing Atypical Antipsychotics to Bifeprunox
- Ziprasidone for Improving Insulin Sensitivity in People With Schizophrenia Who Are at Risk for Diabetes
- Efficacy Study of Early Onset of Antipsychotic Drug Action in Schizophrenia
- Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Acute Dystonia or Parkinsonism
- Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy
- Xyrem for Treatment Refractory Insomnia Due to PTSD
- Ziprasidone And Olanzapine's Outcomes In Mania
- Patient's Preference Between Conventional Oral Olanzapine Tablet vs Olanzapine Orodispersible Tablet
- Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode Psychosis
- Olanzapine Pamoate Depot Versus Oral Olanzapine on Treatment Outcomes in Outpatients With Schizophrenia
- A Study Using Rapid Acting Intramuscular Olanzapine in Agitated Patients With Schizophrenia
- Body Mass Index (BMI) and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and Quetiapine
- A Study to Evaluate the Efficacy and Safety of Adjustable Doses of Extended-release (ER) Paliperidone Compared With Placebo, in Combination With Lithium or Valproate, to Treat Manic and Mixed Episodes in Patients With Bipolar I Disorder
- Comparing the Effect of Under the Tongue Olanzapine Versus Swallowed Olanzapine on Body Mass Index (A Ratio of Weight to Height)
- Influence of Treatment With Olanzapine or Ziprasidone on Transcapillary Glucose Transport in Human Skeletal Muscle
- Appetite Increase in Schizophrenia Patients Treated With Atypical Antipsychotics
- Comparative Effects of Chronic Treatment With Olanzapine and Risperidone on Glucose and Lipid Metabolism
- Study of Amantadine for Weight Stabilization During Olanzapine Treatment
- Aripiprazole in the Treatment of Acutely Relapsed Patients With Schizophrenia
- Sarcosine Preventive Therapy for Individuals At High Risk for Schizophrenia
- PET Imaging and Olanzapine Treatment in Borderline Personality Disorder
- Olanzapine Augmentation Therapy in Treatment-resistant Depression: a Double-blind Placebo-controlled Trial
- Efficacy and Safety of Olanzapine in the Extended Treatment for Manic or Mixed Episode of Bipolar I Disorder
- Study Evaluating SCA-136 in Subjects With Acute Exacerbations of Schizophrenia
- 6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptom Patients Who Completed the Protocol 25543 (25544)(P05777)
- Olanzapine in the Treatment of Patients With Anorexia Nervosa
- SB-773812 Administered In Adults With Schizophrenia
- Validation of Multidimensional Assessment of THYmic States (MATHYS): A Study in a Population of Bipolar Patients Treated With Olanzapine
- A Study of Risperidone Long-Acting Injection Versus Oral Antipsychotics in Schizophrenia Participants With a History of Being Poorly Compliant With Taking Their Medication
- Movement Disorders Caused by Antipsychotic Drugs in Older Patients
- Trial of Aripiprazole in the Treatment of CD in Adolescents
- A Trial Comparing Risperidone Long-Acting Injection With Oral Antipsychotic in the Treatment of Early Psychosis
- A Randomized, Open-label Trial of Long-acting Injectable Risperidone Versus Oral Antipsychotic Medication in Patients With Bipolar Disorder
- Side Effects of Newer Antipsychotics in Older Adults
- Ziprasidone Versus Olanzapine In The Treatment Of Schizophrenia.
- Schizophrenia Trial of Aripiprazole
- Effectiveness of Atypical Versus Conventional Antipsychotics in Treating Schizophrenia
- A Study Comparing the Efficacy of Long-acting Injectable Risperidone and Olanzapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder
- A Study of the Effects of Risperidone and Olanzapine on Blood Glucose (Sugar) in Patients With Schizophrenia or Schizoaffective Disorder
- Trial of Ampakine Added to Clozapine, Olanzapine or Risperidone in Patients With Schizophrenia
- Pioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With Schizophrenia
- Efficacy and Safety Study of Escitalopram Augmentation in Treatment Resistant Schizophrenia
- Patient-reported Outcomes in the Treatment of Schizophrenia
- Propofol Injection for Daily Headache
- Neurocognitive Effects of Ziprasidone: Relationship to Working Memory and Dopamine Blockade
- Study Comparing Patients Taking Olanzapine and Patients Taking Aripiprazole on Learning of Vocational Skills
- A Comparative Study of New Medications for Psychosis in Adolescents
- An Evaluation of Divalproex vs. Olanzapine for Alcohol Abuse Relapse Prevention in Patients With Bipolar Disorder
- A Study of Treatment Success in Changing From Olanzapine to Long-acting Injectable Risperidone (RISPERDAL® CONSTA™)
- A Study of Relapse Prevention and the Effectiveness of Long-acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder
- Efficacy and Safety of Asenapine Compared With Olanzapine in Patients With Persistent Negative Symptoms of Schizophrenia (25543)(COMPLETED)(P05817)
- Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)
- Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25520)(P05846)
- Adjunctive Supplementation of Antioxidants (Vitamins E + C) Plus Omega-3 Fatty Acids
- Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (SFBRI)
- Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (BMS)
- A Study of the Long-term Safety and Tolerability and the Long-term Effectiveness of Extended-release Oral Paliperidone in Patients Diagnosed With Schizophrenia
- A Comparison of Two Standard Therapies in the Management of Dementia With Agitation
- Aripiprazole in Children With Autism: A Pilot Study
- Six Month Trial of Lamotrigine vs. Sodium Valproate for Treatment of Mixed Mania
- Janssen - Glucose Regulation/Risp/Olanz
- Pfizer/IVGTT/Ziprasidone/Olanzapine
- Metabolic Effects of Antipsychotics in Children
- Changes in Adiposity, Metabolic Measures From Atypicals to Aripiprazole
- A Research Study Examining the Use of Olanzapine for the Prevention of Migraine
- Comparison of Combination Olanzapine+Lithium or Chlorpromazine+Lithium in Treatment of First Manic Episode With Psychotic Features
- Pilot Study Evaluating the Safety and Efficacy of Open-Label Olanzapine
- Bifeprunox in the Treatment of Schizophrenia
- Optimal Length of Treatment Continuation With Olanzapine After Remission of Manic or Mixed Episode
- A Study on Induced Weight Gain During Atypical Antipsychotic Treatment and Its Management With Psychoeducational Programme
- Efficacy Study of Switching Stabilized Schizophrenic Patients From Conventional to Atypical Antipsychotic Treatment
- Bipolar Depression Study: Bipolar Depression Assessment Study on Treatment Response
- Olanzapine Plus Carbamazepine in the Treatment of Bipolar I Mania
- Safety Study of Olanzapine and a Comparator in Patients With Schizophrenia and Schizoaffective Disorder
- Clozapine IM and Aggression in Schizophrenic Patients
- A Neuroimaging Investigation of Brain Activity in Major Depressive Disorder and Bipolar Disorder
- Short Term Rescue Study of Olanzapine
- Supported Employment and Skills Training in Conjunction With Pharmacotherapy in Schizophrenia Patients
- Determining the Safety and Effectiveness of Olanzapine in Children and Adolescents
- Long-Term Olanzapine Treatment in Children With Autism
- Olanzapine in the Treatment of Hair Pulling (Trichotillomania)
- Cognition, Functioning and Quality of Life
- Open-Label Comparative Study of Risperidone Versus Olanzapine Versus Quetiapine for Mania in Children and Adolescents With Bipolar I and Bipolar II Disorder
- Risperidone Versus Olanzapine for Mania in Preschool Children 4 to 6 Years of Age With Bipolar Disorder
- Olanzapine Versus Clozapine in Treatment Refractory Schizophrenia
- Effects of Risperidone and Olanzapine on Patients With Schizophrenia, Schizoaffective Disorder, Major Depression or Bipolar Disorder
- Serotonin 1A Agonists and Cognition in Schizophrenia
- Treatment of Geriatric Bipolar Mood Disorders: A Pilot Study
- Efficacy Study of Galantamine for Cognitive Impairments in Schizophrenia
- Risperidone and Divalproex Sodium With MRI Assessment in Pediatric Bipolar
- 6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptoms Patients Who Completed the First 6- Month Trial (A7501014)(COMPLETED)(P05772)
- Effectiveness of Clozapine Versus Olanzapine for Treatment-resistant Schizophrenia
- 3-week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07009)
- 40 Week Extension Study Of Asenapine and Olanzapine For Bipolar Disorder (A7501007)(COMPLETED)(P05857)
- Effect And Safety Of Ziprasidone Compared To Other Atypical Antipsychotic Drug In Schizophrenic Patients
- 3-Week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07008)
- Efficacy and Safety of Asenapine With Placebo and Olanzapine (41021)(P05933)
- Long-Term Efficacy and Safety of Asenapine Using Olanzapine as a Positive Control (41512)(COMPLETED)(P05784)
- Efficacy and Safety of Asenapine With Placebo and Olanzapine (41022)(P05947)
- A First In Human Study Of PF-00184562 In Healthy Volunteers
- Addition of Ondansetron to Ongoing Antipsychotic Treatment for Schizophrenia
- Study of LY2140023 in Schizophrenia Comparing LY2140023, Olanzapine, and Placebo
- Energy Homeostasis Under Treatment With Atypical Antipsychotics
- The Efficacy of Escitalopram for Negative Symptoms in Schizophrenia
- Efficacy and Safety of Asenapine Compared With Olanzapine in Patients With Persistent Negative Symptoms of Schizophrenia (A7501013)(COMPLETED)(P05771)
- Kahn Study; Investigation Of The Efficacy Of Ziprasidone Versus Olanzapine In The Management Of Recent-Onset Psychosis; A Flexible-Dose, Parallel Group, Double-Blind Study
- 9 Week Extension Study of Asenapine and Olanzapine in Treatment of Mania (P07007)(COMPLETED)
- A Double-blind, Placebo Controlled Trial of Risperidone for the Treatment of Anorexia Nervosa
- Clinical Effect Of Cross Titration Of Antipsychotics With Ziprasidone In Schizophrenia Or Schizoaffective Disorder
- Trial of Olanzapine in Patients With Manic or Mixed Episode of Bipolar I Disorder
- Study Comparing Olanzapine With Haloperidol for the Relief of Nausea and Vomiting in Patients With Advanced Cancer
- Olanzapine Treated Adolescents With Schizophrenia or Bipolar I Disorder
- The Effects of Risperidone and Olanzapine on Thinking
- Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder
- Olanzapine Versus Aripiprazole in the Treatment of Acutely Ill Patients With Schizophrenia
- Efficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoaffective Disorder
- Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder
- Pharmacokinetic Characterization of Intramuscular Olanzapine Depot
- Olanzapine vs. Comparator and Placebo in the Treatment of Patients With Bipolar I Disorder
- Olanzapine in Patients With Borderline Personality Disorder
- Comparison of Continuing Olanzapine to Switching to Quetiapine in Overweight or Obese Patients With Schizophrenia and Schizoaffective Disorder
- A Combination of Two Currently Approved Drugs to Enhance the Treatment of Schizophrenia
- Comparison of Intramuscular Olanzapine Depot to Oral Olanzapine and Low-Dose Depot in Patients With Schizophrenia
- Comparison of Intramuscular Olanzapine Depot With Placebo in the Treatment of Patients With Schizophrenia
- Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder
- Study of Olanzapine vs. Aripiprazole in the Treatment of Schizophrenia
- Efficacy and Safety of Olanzapine in Patients With Borderline Personality Disorder
- Trial Evaluating Three Fixed Doses of Paliperidone Extended-Release (ER) Tablets and Olanzapine in the Treatment of Patients With Schizophrenia
- Trial Evaluating Three Fixed Dosages of Paliperidone Extended-Release (ER) Tablets and Olanzapine in the Treatment of Patients With Schizophrenia
- Trial Evaluating the Efficacy and Safety of 2 Fixed Doses of Paliperidone Extended-Release (ER) Tablets in the Treatment of Adult Patients With Schizophrenia
- Depakote ER Plus an Atypical Antipsychotic Vs. an Atypical Antipsychotic Alone in the Treatment of Schizophrenia
- Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depakote Plus Olanzapine in Stable Subjects During the Maintenance Phase of Bipolar Illness
- Atypical Neuroleptic Drugs in People With Mental Retardation/Developmental Delay
- Imaging of Brain Receptors in Healthy Volunteers and in Patients With Schizophrenia
- A Controlled Study of Olanzapine in Children With Autism
- Study of Pharmacotherapy of Psychotic Depression
- Treatment of Early Onset Schizophrenia Spectrum Disorders (TEOSS)
- Olanzapine Versus Placebo in the Treatment of Adolescents With Schizophrenia
- Olanzapine Versus Placebo in the Treatment of Mania in Adolescents With Bipolar I Disorder
- Treating Drug-Resistant Childhood Schizophrenia
- Treatment and Outcome of Early Onset Bipolar Disorder
- Switching Medication to Treat Schizophrenia
- The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder
- Olanzapine Versus An Active Comparator in the Treatment of Schizophrenia
- The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant Depression
- CAFE Comparison of Atypicals in First Episode of Psychosis
- Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With Schizophrenia
- A Study to Assess Safety and Tolerabiltiy Associated With a Switch From Oral Antipsychotic Medications to Long-acting Injectable Risperidone in Patients With Schizophrenia.
- Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder
- Antipsychotic Response in Schizophrenia
- CATIE-Alzheimer's Disease Trial
- CATIE- Schizophrenia Trial
- To Determine if Olanzapine is More Cost Effective Than Haloperidol for the Treatment of Schizophrenia
- Glucose Regulation During Risperidone and Olanzapine Treatment
- Comparison of Clozapine vs Olanzapine in Childhood-Onset Psychotic Disorders
- Treatment for First-Episode Schizophrenia
- Treatment of Obsessive-Compulsive Disorder
Clinical trials list
click for details